Adient plc
NYSE:ADNTAuto - Parts
+$0.21 today
- Market cap
- $1.15B
- Beta
- 1.51
- P/E (TTM)
- 27.8
- EPS (TTM)
- $0.74
Volume 1.72M
Average 0.97M
ADNT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Adient plcNYSE: ADNT
Research & Development · Q2 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $387M. Over 3 fiscal years it compounded at +6.3% a year.
Context
- Research & development amounted to 2.7% of revenue in FY2025, up 0.1 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $96.75M.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 387M USD
- Year-over-year change
- +4.0%
- 4-year CAGR
- +5.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 387M | +4.0% |
| FY2024 | 2024-09-30 | 372M | +2.8% |
| FY2023 | 2023-09-30 | 362M | +12.4% |
| FY2022 | 2022-09-30 | 322M | +1.9% |
| FY2021 | 2021-09-30 | 316M | — |
Research & Development vs competitors
How ADNT compares with its peers on the latest reported figures
- ADNT's LTM Mar 2026 research & development of $387M is the 2nd highest of the 14 companies compared; the peer median is $0.
- Its year-over-year change of +4.0% is the 5th highest of 10, against a peer median of -14.7%.
- Research & development amounts to 2.6% of revenue for ADNT, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $453M | +22.1% | +1.9% | 4.1% | |
| LTM Mar 2026 | $387M | +4.0% | +6.3% | 2.6% | |
| LTM Sep 2026 | $205.71M | +4.4% | +15.1% | 7.9% | |
| LTM Sep 2026 | $157M | -14.7% | -2.0% | 3.5% | |
| LTM Apr 2026 | $70.86M | +12.6% | +7.3% | 4.8% | |
| LTM Mar 2026 | $54.03M | -25.1% | -2.7% | 6.7% | |
| LTM Mar 2026 | $14.2M | +24.5% | +11.2% | 1.8% | |
| LTM Oct 2026 | $0 | -100.0% | +6.6% | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | -31.1% | — | |
| LTM Jun 2026 | $0 | -100.0% | +3.9% | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ADNT) | $0 | -14.7% | +3.9% | 0.9% | |
Competitors are the stored peer set for ADNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 13.68B | 14.12B | 15.4B | 14.69B | 14.54B |
| Cost of Revenue | 12.85B | 13.31B | 14.36B | 13.76B | 13.57B |
| Gross Profit | 826M | 807M | 1.03B | 928M | 961M |
| Gross Margin | 6.0% | 5.7% | 6.7% | 6.3% | 6.6% |
| Research & Development | 316M | 322M | 362M | 372M | 387M |
| Selling, General & Admin | 537M | 598M | 554M | 507M | 522M |
| Operating Expenses | 537M | 598M | 554M | 507M | 522M |
| Depreciation & Amortization | 330M | 350M | 340M | 332M | 325M |
| EBITDA | 2.03B | 603M | 828M | 656M | 438M |
| EBITDA Margin | 14.8% | 4.3% | 5.4% | 4.5% | 3.0% |
| Operating Income | 289M | 209M | 479M | 421M | 439M |
| Operating Margin | 2.1% | 1.5% | 3.1% | 2.9% | 3.0% |
| Interest Income | 7M | 9M | 22M | 10M | 24M |
| Interest Expense | 258M | 188M | 203M | 191M | 205M |
| Other Income / Expenses | 1.15B | (155M) | (184M) | (288M) | (527M) |
| Income Before Tax | 1.44B | 54M | 295M | 133M | (88M) |
| Pre-Tax Margin | 10.5% | 0.4% | 1.9% | 0.9% | -0.6% |
| Income Tax Expense | 249M | 94M | 0 | 32M | 103M |
| Net Income | 1.11B | (120M) | 205M | 18M | (281M) |
| Net Margin | 8.1% | -0.8% | 1.3% | 0.1% | -1.9% |
| EPS (Basic) | 11.76 | (1.27) | 2.17 | 0.20 | (3.39) |
| EPS (Diluted) | 11.58 | (1.27) | 2.15 | 0.20 | (3.39) |
| Weighted Avg Shares | 94.2M | 94.8M | 94.5M | 89.5M | 83M |
| Weighted Avg Shares (Diluted) | 95.7M | 94.8M | 95.4M | 90.1M | 83M |
Adient plc
NYSE:ADNT
Intrinsic Alpha fair value
Locked
Current Price
$15.44
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.